Treatment Strategy After Endoscopic Resection for Colorectal T1(SM) Cancer: Present Status and Future Perspective

  • Shinji TanakaEmail author
  • Shiro Oka
  • Kazuaki Chayama


Recent progress of endoscopy such as endoscopic submucosal dissection (ESD) enabled to resect Tis/T1 colorectal cancer endoscopically en bloc regardless of its size. In this chapter, we assessed the present status and future perspective of management for Tis/T1 colorectal cancer. Recently, according to the accumulation of many cases and detailed evaluation, after complete endoscopic en bloc resection for T1 colorectal cancer, if below all conditions are satisfied in histological examination, it can be considered curative resection: (1) submucosal invasion depth less than 1000 μm, (2) favorable histologic grade, (3) no vessel involvement, and (4) low budding grade. On the other hand, recent studies revealed that even for T1b cancer, if there are no other metastatic risk factors, estimated lymph node metastatic risk is 1.2–0.4%. On the basis of this evidence, endoscopic treatment is gradually becoming more commonly used to achieve total excisional biopsy even for cT1b colorectal carcinoma. At present, there has been evaluated as clinical research regarding the feasibility of endoscopic resection as total excisional biopsy for T1 cancer that have previously been indicated for surgery. In the future, it is expected to be able to apply molecular markers for judgment for curability after endoscopic resection.


T1 colorectal cancer Colorectal SM cancer Lymph node metastasis Endoscopic resection Additional surgery 


  1. 1.
    JSCCR (Japanese Society for Cancer of the Colon and Rectum) guidelines for the treatment of colorectal cancer 2016. Tokyo: Kanahara Shuppan; 2016.Google Scholar
  2. 2.
    Tanaka S, Asayama N, Shigita K, et al. Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: future perspective. Dig Endosc. 2015;27:216–22; (Review).CrossRefGoogle Scholar
  3. 3.
    Nakadoi K, Tanaka S, Kanao H, et al. Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol. 2011;27:1057–62.CrossRefGoogle Scholar
  4. 4.
    Yoshii S, Nojima M, Nosho K, et al. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin Gastroenterol Hepatol. 2014;12:292–302.CrossRefGoogle Scholar
  5. 5.
    Yoda Y, Ikematsu H, Matsuda T, et al. A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancer. Endoscopy. 2013;45:718–24.CrossRefGoogle Scholar
  6. 6.
    Kobayashi H, Mochizuki H, Morita T, et al. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol. 2011;46:203–11.CrossRefGoogle Scholar
  7. 7.
    Report of survey in 2009. The database committee of the Japanese Society of Gastroenterological Surgery.Google Scholar
  8. 8.
    Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy. 1993;25:455–61.CrossRefGoogle Scholar
  9. 9.
    Saitoh Y, Obara T, Einami K, et al. Efficacy of high-frequency ultrasound probes for the preoperative staging of invasion depth in flat and depressed colorectal tumors. Gastrointest Endosc. 1996;44:34–9.CrossRefGoogle Scholar
  10. 10.
    Ozawa S, Tanaka S, Hayashi N, et al. Risk factors for vertical incomplete resection in endoscopic submucosal dissection as total excisional biopsy for submucosal invasive colorectal carcinoma. Int J Color Dis. 2013;28:1247–56.CrossRefGoogle Scholar
  11. 11.
    Aoki R, Tanaka S, Haruma K, et al. MUC1 expression as a predictor of the curative endoscopic treatment of submucosal invasive colorectal carcinoma. Dis Colon Rectum. 1998;41:1262–72.CrossRefGoogle Scholar
  12. 12.
    Oh-e H, Tanaka S, Kitadai Y, et al. Angiogenesis at the site of deepest penetration predicts lymph node metastasis of submucosal colorectal cancer. Dis Colon Rectum. 2001;44:1129–36.CrossRefGoogle Scholar
  13. 13.
    Oh-e H, Tanaka S, Kitadai Y, et al. Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer. Eur J Cancer. 2001;37:180–8.CrossRefGoogle Scholar
  14. 14.
    Tanaka S, Oka S, Tamura T, et al. Molecular pathologic application as a predictor of lymph node metastasis in submucosal colorectal carcinoma: implication of immunohistochemical alteration as the deepest invasive margin. In: Muto T, Mochizuki H, Masaki T, editors. Tumor budding in colorectal cancer: recent progress in colorectal cancer research. Hauppauge, NY: NOVA; 2006. p. 171–80.Google Scholar
  15. 15.
    Kawachi H, Eishi Y, Ueno H, et al. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol. 2015;28:872–9.CrossRefGoogle Scholar
  16. 16.
    Ueno H, Hase K, Hashiguchi Y, et al. Novel risk factors for lymph node metastasis in early invasive colorectal cancer: a multi-institution pathology review. J Gastroenterol. 2014;49:1314–23.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of EndoscopyHiroshima University HospitalHiroshimaJapan
  2. 2.Department of Gastroenterology and MetabolismHiroshima University HospitalHiroshimaJapan

Personalised recommendations